Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C testing: interpretation, implications, and counseling

P R Becherer1, B Bacon

  • 1St. Louis University Medical Center, Department of Internal Medicine, MO 63104.

Missouri Medicine
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.

Alimentary pharmacology & therapeutics·2018
Same author

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.

Alimentary pharmacology & therapeutics·2017
Same author

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

Journal of viral hepatitis·2013
Same author

Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.

Genes and immunity·2012
Same author

Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients.

Journal of viral hepatitis·2004
Same author

Report of the FELASA Working Group on evaluation of quality systems for animal units.

Laboratory animals·2004
Same journal

Save the Date!: 169th Annual Convention | April 2-4, 2027, InterContinental at the Plaza | Kansas City, Missouri.

Missouri medicine·2026
Same journal

Inequity in Physician Compensation Is Killing Private Practice.

Missouri medicine·2026
Same journal

Sweetness at a Cost: The Story and Science of High-Fructose Corn Syrup.

Missouri medicine·2026
Same journal

The Role of Artificial Intelligence in Acute Ischemic Stroke Care: A Narrative Review.

Missouri medicine·2026
Same journal

Long-Term Cardiac Rhythm Monitoring After Ischemic Stroke: Detecting Atrial Fibrillation in the Era of Atrial Cardiopathy.

Missouri medicine·2026
Same journal

Recipients of the 50-Year Physician Pin.

Missouri medicine·2026
See all related articles

Hepatitis C virus (HCV) is now recognized as a primary cause of non-A, non-B hepatitis. Diagnostic tests for HCV antibodies need careful interpretation due to sensitivity and specificity issues.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) identified as the primary cause of non-A, non-B hepatitis.
  • Molecular biology advancements enabled this identification.

Purpose of the Study:

  • To highlight the significance of serologic assays for HCV detection.
  • To emphasize the need for cautious interpretation of these assays.
  • To outline the comprehensive evaluation required for suspected HCV infection.

Main Methods:

  • Utilized new molecular biology techniques for viral identification.
  • Employed serologic assays to detect HCV-specific antibodies.
  • Clinical evaluation to assess infection presence and liver damage extent.

Related Experiment Videos

Main Results:

  • HCV confirmed as the major cause of non-A, non-B hepatitis.
  • Serologic assays represent a significant diagnostic advancement.
  • Identified limitations in test sensitivity and specificity requiring careful interpretation.

Conclusions:

  • Suspected HCV infections warrant thorough evaluation.
  • Assessment should confirm infection, rule out other liver diseases, and determine damage extent.
  • Treatment decisions should follow comprehensive patient evaluation.